Research Laboratory Scientist for Oncolytic Virus-based Cancer Immunology (m/f/d) Job Details | BoehringerPRD

Research Laboratory Scientist for Oncolytic Virus-based Cancer Immunology (m/f/d)

The position

Viratherapeutics, a subsidiary of the Boehringer Ingelheim group, combines the agility of a biotech start-up with the resources of a large pharmaceutical company. Our team in Innsbruck, Austria - a vibrant city known for its quality of life—is dedicated to developing innovative viral-based immuno-oncology therapies. As part of our dynamic oncology R&D unit, you will be part of a team to discover and develop novel cancer treatments, bringing breakthrough therapies from the lab to clinical practice.

We are looking for a highly motivated and creative Research Laboratory Scientist for cancer immunology research to support the development of cancer vaccines.

Tasks & responsibilities

Requirements

Essential:

Preferred Requirements:

Your Benefits

The remuneration for this position starts at € 50,000.00 gross per year (full-time), plus allowances and attractive social benefits (e.g. public transport ticket, meal allowance, team events, health and sports offering). The actual base salary will be in line with your qualifications, experience, and individual competencies.

We are looking forward to receiving your application online!

By uploading your application documents via our application portal, we can treat your data confidentially and in compliance with the GDPR.

Do you have any additional questions about the position? Your HR Recruiting Manager for this position is Anja Diestel.

Our Company

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,300 employees serve over 130 markets to build a healthier and more sustainable tomorrow.